Hypertension Diagnostics, Inc. (HDII)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 7, 2025
Hypertension Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2018 | FY 2017 | FY 2016 | FY 2012 | FY 2011 | 2006 - 2010 |
|---|---|---|---|---|---|---|
Period Ending | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Jun '12 Jun 30, 2012 | Jun '11 Jun 30, 2011 | 2006 - 2010 |
| Revenue | 3.79 | 3.68 | 3.57 | 3.16 | - | Upgrade
|
| Revenue Growth (YoY) | 3.11% | 3.10% | 12.96% | - | - | Upgrade
|
| Cost of Revenue | 2.84 | 2.93 | 3.02 | 3.27 | - | Upgrade
|
| Gross Profit | 0.95 | 0.75 | 0.55 | -0.11 | - | Upgrade
|
| Selling, General & Admin | 0.92 | 0.97 | 1.02 | 1.19 | 0.33 | Upgrade
|
| Other Operating Expenses | - | - | - | 0.05 | 0.03 | Upgrade
|
| Operating Expenses | 0.95 | 1 | 1.05 | 1.24 | 0.36 | Upgrade
|
| Operating Income | 0 | -0.24 | -0.5 | -1.36 | -0.36 | Upgrade
|
| Interest Expense | -0.16 | -0.16 | -0.16 | -0.14 | - | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.01 | 0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -0.13 | -0.37 | -0.62 | -1.47 | -0.36 | Upgrade
|
| Pretax Income | -0.13 | -0.37 | -0.62 | -1.47 | -0.36 | Upgrade
|
| Earnings From Continuing Operations | -0.13 | -0.37 | -0.62 | -1.47 | -0.36 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 0.21 | 0.76 | Upgrade
|
| Net Income | -0.13 | -0.37 | -0.62 | -1.26 | 0.41 | Upgrade
|
| Net Income to Common | -0.13 | -0.37 | -0.62 | -1.26 | 0.41 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 52 | 52 | 47 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 52 | 52 | 54 | 50 | Upgrade
|
| Shares Change (YoY) | - | - | -3.26% | 8.34% | 21.09% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.03 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.03 | 0.01 | Upgrade
|
| Free Cash Flow | -0.39 | -0.09 | -0.39 | -1.86 | -0.2 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.03 | -0.00 | Upgrade
|
| Gross Margin | 25.17% | 20.46% | 15.45% | -3.54% | - | Upgrade
|
| Operating Margin | 0.02% | -6.66% | -14.03% | -42.95% | - | Upgrade
|
| Profit Margin | -3.31% | -10.02% | -17.43% | -40.01% | - | Upgrade
|
| Free Cash Flow Margin | -10.32% | -2.39% | -10.85% | -58.78% | - | Upgrade
|
| EBITDA | 0.04 | -0.21 | -0.47 | -1.25 | -0.36 | Upgrade
|
| EBITDA Margin | 0.97% | -5.81% | -13.06% | -39.56% | - | Upgrade
|
| D&A For EBITDA | 0.04 | 0.03 | 0.03 | 0.11 | 0 | Upgrade
|
| EBIT | 0 | -0.24 | -0.5 | -1.36 | -0.36 | Upgrade
|
| EBIT Margin | 0.02% | -6.66% | -14.03% | -42.95% | - | Upgrade
|
| Revenue as Reported | 3.79 | 3.68 | 3.57 | 3.16 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.